Lixte Biotechnology Holdings Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.04 |
Market Cap |
$70.4 M |
Shares Outstanding |
67.05 M |
Public Float |
8.11 M |
Address |
248 Route 25A No. 2 East Setauket New York 11733 United States |
Employees | - |
Website | http://www.lixte.com |
Updated | 07/08/2019 |
Lixte Biotechnology Holdings, Inc. engages in the development of drugs for cancer treatment. It uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company was founded by John S. |